pilocarpine has been researched along with HIV Infections in 2 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
Excerpt | Relevance | Reference |
---|---|---|
" From studies published 2002 to 2005, 15 were identified as high-quality studies and were used to support management recommendations: pilocarpine and cevimeline are recommended for treating hyposalivation and xerostomia in primary and secondary Sjögren's syndrome (SS)." | 4.84 | Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. ( Brennan, MT; Carrozzo, M; Daniels, T; Fox, PC; Fujibayashi, T; Gandera, B; Jonsson, R; Lockhart, PB; Navazesh, M; Rhodus, NL; Schiødt, M; Sollecito, TP; von Bültzingslöwen, I; Wray, D, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shetty, K | 1 |
von Bültzingslöwen, I | 1 |
Sollecito, TP | 1 |
Fox, PC | 1 |
Daniels, T | 1 |
Jonsson, R | 1 |
Lockhart, PB | 1 |
Wray, D | 1 |
Brennan, MT | 1 |
Carrozzo, M | 1 |
Gandera, B | 1 |
Fujibayashi, T | 1 |
Navazesh, M | 1 |
Rhodus, NL | 1 |
Schiødt, M | 1 |
1 review available for pilocarpine and HIV Infections
Article | Year |
---|---|
Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Diabetes Complicat | 2007 |
1 other study available for pilocarpine and HIV Infections
Article | Year |
---|---|
Dentistry. Implications and management of xerostomia in the HIV patient.
Topics: Antiretroviral Therapy, Highly Active; Cholinergic Agents; HIV Infections; HIV Protease Inhibitors; | 2005 |